Common Dreams NewsCenter

We Can't Do It Without You!
 

Home | About Us | Donate | Signup | Archives | Search

Home > Progressive Community > NewsWire > For Immediate Release
   
Printer Friendly Version E-Mail This Article
   
Institute for Public Accuracy

FOR IMMEDIATE RELEASE
JANUARY 20, 2006
1:00 PM

CONTACT: Institute for Public Accuracy
Sam Husseini, (202) 347-0020; or David Zupan, (541) 484-9167

 
Roots of Medicare Drug Problems
 

WASHINGTON - January 20 -

DEAN BAKER
Co-director of the Center for Economic and Policy Research, Baker wrote the just-released report "The Savings from an Efficient Medicare Prescription Drug Benefit." Baker said today: "The Medicare Modernization Act costs the government and beneficiaries considerably more than is necessary. If Medicare could negotiate directly with drug companies it could save the federal and state governments hundred of billions of dollars and cut insurance premiums. ... The potential savings are so large that the current projected budget for the program would be enough to fully finance the benefit with no contribution from the beneficiaries whatsoever."
"The Savings from an Efficient Medicare Prescription Drug Benefit" (PDF)
More Information


JOHN GEYMAN
Geyman is professor emeritus of family medicine at the University of Washington School of Medicine. He is president of Physicians for a National Health Program and author of the new book Shredding the Social Contract: The Privatization of Medicare.
More Information


DEBORAH S. SOCOLAR
Co-Director of the Health Reform Program at Boston University School of Public Health, Socolar said today: "The Medicare drug benefit is confusing, very thin, full of holes, and far costlier than it has to be. That's because the drug industry demanded that the benefit be provided through many competing private insurance plans -- rather than directly through Medicare -- and President Bush and Congress agreed.

"Since many private insurers are now individually negotiating Medicare's prices with drug companies, they pay much more than the Veterans Administration and governments in other countries do. And high prices mean that the program's budget won't stretch very far.

"So Congress designed the drug benefit with a huge coverage gap in the middle. Many of our neediest citizens will fall into this 'black hole' and never get out, if they can't pay for enough drugs themselves to reach the threshold for catastrophic coverage. But if Medicare paid prices comparable to those in other countries, there would be no need for such a hole. High prices also mean drug manufacturers can garner extraordinary profits from this plan, because it will cost them very little to make the additional pills that our seniors need."
More Information

###

Printer Friendly Version E-Mail This Article
Common Dreams NewsCenter is a non-profit news service
providing breaking news and views for the Progressive Community.

The press release posted here has been provided to Common Dreams NewsWire by one of the many progressive organizations who make up America's Progressive Community. If you wish to comment on this press release or would like more information, please contact the organization directly.
*all times Eastern US (GMT-5:00)

Making News?
Read our Guidelines for Submitting News Releases

CommonDreams.org is an Internet-based progressive news and grassroots activism organization, founded in 1997.
We are a nonprofit, progressive, independent and nonpartisan organization.

Home | About Us | Donate | Signup | Archives | Search

To inform. To inspire. To ignite change for the common good.


www.commondreams.org